204 related articles for article (PubMed ID: 2189460)
1. Magnetic resonance imaging of the prostate and bladder.
Piccoli CW; Rifkin MD
Top Magn Reson Imaging; 1990 Jun; 2(3):51-66. PubMed ID: 2189460
[TBL] [Abstract][Full Text] [Related]
2. [Endorectal magnetic resonance imaging of the prostate and bladder].
Sugimura Y; Hayashi N; Yamashita A; Kinbara H; Arima K; Tochigi H; Kawamura J
Hinyokika Kiyo; 1994 Jan; 40(1):31-6. PubMed ID: 7509118
[TBL] [Abstract][Full Text] [Related]
3. Contrast-enhanced MR imaging of the bladder and prostate.
Siegelman ES; Schnall MD
Magn Reson Imaging Clin N Am; 1996 Feb; 4(1):153-69. PubMed ID: 8673712
[TBL] [Abstract][Full Text] [Related]
4. [The clinical value of preoperative staging of bladder and prostatic cancers with nuclear magnetic resonance and computerized tomography].
Beer M; Schmidt H; Riedl R
Urologe A; 1989 Mar; 28(2):65-9. PubMed ID: 2718295
[TBL] [Abstract][Full Text] [Related]
5. [The progress in diagnostic imaging for staging of bladder and prostate cancer: endorectal magnetic resonance imaging and magnetization transfer contrast].
Arima K; Hayashi N; Yanagawa M; Kawamura J; Kobayashi S; Takeda K; Sugimura Y
Hinyokika Kiyo; 1999 Aug; 45(8):553-7. PubMed ID: 10500962
[TBL] [Abstract][Full Text] [Related]
6. MRI of the prostate.
Rifkin MD
Crit Rev Diagn Imaging; 1990; 31(2):223-62. PubMed ID: 2288663
[TBL] [Abstract][Full Text] [Related]
7. Potential and limitations of diffusion-weighted magnetic resonance imaging in kidney, prostate, and bladder cancer including pelvic lymph node staging: a critical analysis of the literature.
Giannarini G; Petralia G; Thoeny HC
Eur Urol; 2012 Feb; 61(2):326-40. PubMed ID: 22000497
[TBL] [Abstract][Full Text] [Related]
8. Transitional cell carcinoma involving the prostate with a proposed staging classification for stromal invasion.
Esrig D; Freeman JA; Elmajian DA; Stein JP; Chen SC; Groshen S; Simoneau A; Skinner EC; Lieskovsky G; Boyd SD; Cote RJ; Skinner DG
J Urol; 1996 Sep; 156(3):1071-6. PubMed ID: 8709310
[TBL] [Abstract][Full Text] [Related]
9. [Determining the depth of infiltration in urinary bladder carcinoma with contrast medium enhanced dynamic magnetic resonance tomography. With reference to postoperative findings and inflammation].
Venz S; Ilg J; Ebert T; Hierholzer J; Friedrichs R; Hosten N; Felix R
Urologe A; 1996 Jul; 35(4):297-304. PubMed ID: 8928358
[TBL] [Abstract][Full Text] [Related]
10. MR imaging of the bladder.
Mallampati GK; Siegelman ES
Magn Reson Imaging Clin N Am; 2004 Aug; 12(3):545-55, vii. PubMed ID: 15271370
[TBL] [Abstract][Full Text] [Related]
11. Staging and prognosis of T3b bladder cancer.
Levy DA; Grossman HB
Semin Urol Oncol; 1996 May; 14(2):56-61. PubMed ID: 8734732
[TBL] [Abstract][Full Text] [Related]
12. Clinical panurothelial disease in patients with superficial bladder tumors: therapeutic implications.
Solsona E; Iborra I; Ricos JV; Monros JL; Rubio J; Almenar S
J Urol; 2002 May; 167(5):2007-11. PubMed ID: 11956428
[TBL] [Abstract][Full Text] [Related]
13. The validity of magnetic resonance imaging (MRI) in the staging of bladder cancer: comparison with computed tomography (CT) and transurethral ultrasonography (US).
Nishimura K; Hida S; Nishio Y; Ohishi K; Okada Y; Okada K; Yoshida O; Nishimura K; Nishibuchi S
Jpn J Clin Oncol; 1988 Sep; 18(3):217-26. PubMed ID: 3045372
[TBL] [Abstract][Full Text] [Related]
14. Evaluating localized prostate cancer and identifying candidates for focal therapy.
Sartor AO; Hricak H; Wheeler TM; Coleman J; Penson DF; Carroll PR; Rubin MA; Scardino PT
Urology; 2008 Dec; 72(6 Suppl):S12-24. PubMed ID: 19095124
[TBL] [Abstract][Full Text] [Related]
15. [Clinical application of MRI for urological malignancy. 3: A new trial of MRI for bladder cancer and prostatic cancer; surface coil and GD-DTPA].
Nishimura K; Hida S; Nishio Y; Yoshida O; Nakano Y
Hinyokika Kiyo; 1988 Dec; 34(12):2097-100. PubMed ID: 3239521
[TBL] [Abstract][Full Text] [Related]
16. Phased array magnetic resonance imaging for staging clinically localised prostrate cancer.
Borre M; Lundorf E; Marcussen N; Langkilde NC; Wolf H
Acta Oncol; 2005; 44(6):589-92. PubMed ID: 16294442
[TBL] [Abstract][Full Text] [Related]
17. Prostatic tumor relapse in patients with superficial bladder tumors: 15-year outcome.
Herr HW; Donat SM
J Urol; 1999 Jun; 161(6):1854-7. PubMed ID: 10332452
[TBL] [Abstract][Full Text] [Related]
18. Dynamic gadolinium-enhanced magnetic resonance imaging in staging of superficial bladder cancer.
Scattoni V; Da Pozzo LF; Colombo R; Nava L; Rigatti P; De Cobelli F; Vanzulli A; Del Maschio A
J Urol; 1996 May; 155(5):1594-9. PubMed ID: 8627831
[TBL] [Abstract][Full Text] [Related]
19. Prostatic biology, histologic patterns and clinical consequences of transitional cell carcinoma.
Lerner SP; Colen J; Shen S
Curr Opin Urol; 2008 Sep; 18(5):508-12. PubMed ID: 18670276
[TBL] [Abstract][Full Text] [Related]
20. [Current role of MRI for the local staging of prostate cancer].
Busquets JC; Batlle JC; Obregón JB; Ortega MV; Morell NR
Arch Esp Urol; 2006 Dec; 59(10):1001-10. PubMed ID: 17283713
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
